Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Global Veterinary Medicines and Vaccines Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Veterinary Medicines and Vaccines Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global Veterinary Medicines and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Medicines
    • 1.4.3 Vaccines
  • 1.5 Market by Application
    • 1.5.1 Global Veterinary Medicines and Vaccines Market Share by Application: 2020 VS 2026
    • 1.5.2 Companion Animals
    • 1.5.3 Farm Animals
  • 1.6 Coronavirus Disease 2019 (Covid-19): Veterinary Medicines and Vaccines Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global Veterinary Medicines and Vaccines Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Veterinary Medicines and Vaccines Growth Trends by Regions
    • 2.2.1 Veterinary Medicines and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Veterinary Medicines and Vaccines Historic Market Share by Regions (2015-2020)
    • 2.2.3 Veterinary Medicines and Vaccines Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Veterinary Medicines and Vaccines Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Veterinary Medicines and Vaccines Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Veterinary Medicines and Vaccines Players by Market Size
    • 3.1.1 Global Top Veterinary Medicines and Vaccines Players by Revenue (2015-2020)
    • 3.1.2 Global Veterinary Medicines and Vaccines Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Veterinary Medicines and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Veterinary Medicines and Vaccines Market Concentration Ratio
    • 3.2.1 Global Veterinary Medicines and Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Veterinary Medicines and Vaccines Revenue in 2019
  • 3.3 Veterinary Medicines and Vaccines Key Players Head office and Area Served
  • 3.4 Key Players Veterinary Medicines and Vaccines Product Solution and Service
  • 3.5 Date of Enter into Veterinary Medicines and Vaccines Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global Veterinary Medicines and Vaccines Historic Market Size by Type (2015-2020)
  • 4.2 Global Veterinary Medicines and Vaccines Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Veterinary Medicines and Vaccines Market Size by Application (2015-2020)
  • 5.2 Global Veterinary Medicines and Vaccines Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 6.2 Veterinary Medicines and Vaccines Key Players in North America (2019-2020)
  • 6.3 North America Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 6.4 North America Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 7.2 Veterinary Medicines and Vaccines Key Players in Europe (2019-2020)
  • 7.3 Europe Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 7.4 Europe Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 8.2 Veterinary Medicines and Vaccines Key Players in China (2019-2020)
  • 8.3 China Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 8.4 China Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 9.2 Veterinary Medicines and Vaccines Key Players in Japan (2019-2020)
  • 9.3 Japan Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 9.4 Japan Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 10.2 Veterinary Medicines and Vaccines Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 11.2 Veterinary Medicines and Vaccines Key Players in India (2019-2020)
  • 11.3 India Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 11.4 India Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America Veterinary Medicines and Vaccines Market Size (2015-2020)
  • 12.2 Veterinary Medicines and Vaccines Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Veterinary Medicines and Vaccines Market Size by Type (2015-2020)
  • 12.4 Central & South America Veterinary Medicines and Vaccines Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Zoetis
    • 13.1.1 Zoetis Company Details
    • 13.1.2 Zoetis Business Overview and Its Total Revenue
    • 13.1.3 Zoetis Veterinary Medicines and Vaccines Introduction
    • 13.1.4 Zoetis Revenue in Veterinary Medicines and Vaccines Business (2015-2020))
    • 13.1.5 Zoetis Recent Development and Reaction to COVID-19
  • 13.2 Boehringer Ingelheim
    • 13.2.1 Boehringer Ingelheim Company Details
    • 13.2.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 13.2.3 Boehringer Ingelheim Veterinary Medicines and Vaccines Introduction
    • 13.2.4 Boehringer Ingelheim Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.2.5 Boehringer Ingelheim Recent Development and Reaction to COVID-19
  • 13.3 Merck Animal Health
    • 13.3.1 Merck Animal Health Company Details
    • 13.3.2 Merck Animal Health Business Overview and Its Total Revenue
    • 13.3.3 Merck Animal Health Veterinary Medicines and Vaccines Introduction
    • 13.3.4 Merck Animal Health Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.3.5 Merck Animal Health Recent Development and Reaction to COVID-19
  • 13.4 Elanco Animal Health
    • 13.4.1 Elanco Animal Health Company Details
    • 13.4.2 Elanco Animal Health Business Overview and Its Total Revenue
    • 13.4.3 Elanco Animal Health Veterinary Medicines and Vaccines Introduction
    • 13.4.4 Elanco Animal Health Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.4.5 Elanco Animal Health Recent Development and Reaction to COVID-19
  • 13.5 Bayer Animal Health
    • 13.5.1 Bayer Animal Health Company Details
    • 13.5.2 Bayer Animal Health Business Overview and Its Total Revenue
    • 13.5.3 Bayer Animal Health Veterinary Medicines and Vaccines Introduction
    • 13.5.4 Bayer Animal Health Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.5.5 Bayer Animal Health Recent Development and Reaction to COVID-19
  • 13.6 Virbac
    • 13.6.1 Virbac Company Details
    • 13.6.2 Virbac Business Overview and Its Total Revenue
    • 13.6.3 Virbac Veterinary Medicines and Vaccines Introduction
    • 13.6.4 Virbac Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.6.5 Virbac Recent Development and Reaction to COVID-19
  • 13.7 Dechra Veterinary Products
    • 13.7.1 Dechra Veterinary Products Company Details
    • 13.7.2 Dechra Veterinary Products Business Overview and Its Total Revenue
    • 13.7.3 Dechra Veterinary Products Veterinary Medicines and Vaccines Introduction
    • 13.7.4 Dechra Veterinary Products Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.7.5 Dechra Veterinary Products Recent Development and Reaction to COVID-19
  • 13.8 Ceva
    • 13.8.1 Ceva Company Details
    • 13.8.2 Ceva Business Overview and Its Total Revenue
    • 13.8.3 Ceva Veterinary Medicines and Vaccines Introduction
    • 13.8.4 Ceva Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.8.5 Ceva Recent Development and Reaction to COVID-19
  • 13.9 Vetoquinol
    • 13.9.1 Vetoquinol Company Details
    • 13.9.2 Vetoquinol Business Overview and Its Total Revenue
    • 13.9.3 Vetoquinol Veterinary Medicines and Vaccines Introduction
    • 13.9.4 Vetoquinol Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.9.5 Vetoquinol Recent Development and Reaction to COVID-19
  • 13.10 Meiji
    • 13.10.1 Meiji Company Details
    • 13.10.2 Meiji Business Overview and Its Total Revenue
    • 13.10.3 Meiji Veterinary Medicines and Vaccines Introduction
    • 13.10.4 Meiji Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 13.10.5 Meiji Recent Development and Reaction to COVID-19
  • 13.11 Ouro Fino Saude
    • 10.11.1 Ouro Fino Saude Company Details
    • 10.11.2 Ouro Fino Saude Business Overview and Its Total Revenue
    • 10.11.3 Ouro Fino Saude Veterinary Medicines and Vaccines Introduction
    • 10.11.4 Ouro Fino Saude Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 10.11.5 Ouro Fino Saude Recent Development and Reaction to COVID-19
  • 13.12 Parnell
    • 10.12.1 Parnell Company Details
    • 10.12.2 Parnell Business Overview and Its Total Revenue
    • 10.12.3 Parnell Veterinary Medicines and Vaccines Introduction
    • 10.12.4 Parnell Revenue in Veterinary Medicines and Vaccines Business (2015-2020)
    • 10.12.5 Parnell Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Veterinary Medicines and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Medicines and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Veterinary Medicines and Vaccines market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Veterinary Medicines and Vaccines industry.

    The key players covered in this study
    Zoetis
    Boehringer Ingelheim
    Merck Animal Health
    Elanco Animal Health
    Bayer Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Parnell

    Market segment by Type, the product can be split into
    Medicines
    Vaccines
    Market segment by Application, split into
    Companion Animals
    Farm Animals

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Veterinary Medicines and Vaccines status, future forecast, growth opportunity, key market and key players.
    To present the Veterinary Medicines and Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Veterinary Medicines and Vaccines are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
    Buy now